Niti Goel
0000-0001-5869-5157
59 papers found
Refreshing results…
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies.
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA.
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).
Certolizumab pegol
Perceived Functioning Has Ethnic-specific Associations in Systemic Sclerosis: Another Dimension of Personalized Medicine
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.
Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors
Primary Care House Staff Attitudes Toward Osteoporosis Management:
Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
Mechanical sensation and pain thresholds in patients with chronic arthropathies
Pericardial Effusion and Cardiomyopathy Following Arthritis with Parvovirus B19 Infection: Response to Intravenous Immunoglobulin:
Systemic lupus erythematosus in three ethnic groups: IV. Factors associated with self‐reported functional outcome in a large cohort study
Comparison of an Enzyme Immunoassay to an Indirect Fluorescent Immunoassay for the Detection of Antinuclear Antibodies
Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance
Genetic analysis of multiplex rheumatoid arthritis families
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course
Antiphospholipid Antibody Syndrome: Current Concepts
Lack of correlation between serum soluble fas/APO-1 levels and autoimmune disease
Missing publications? Search for publications with a matching author name.